Related Experiment Video
Updated: May 27, 2026

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b
Published on: November 11, 2016
Exploring HCN channels as novel drug targets
1Center for Drug Research, Department of Pharmacy, Ludwig-Maximilians-Universität München, Butenandtstr. 7, 81377 Munich, Germany.
Insights
Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are crucial for heart rate and neuronal activity. Modulating these channels with drugs like ivabradine shows therapeutic potential for various conditions.
Area of Science:
- Pharmacology
- Neuroscience
- Cardiology
Background:
- Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels play vital roles in regulating heart rate and neuronal excitability.
- Ivabradine, a selective HCN channel blocker, is clinically approved for angina treatment, highlighting therapeutic potential.
Purpose of the Study:
- To review current compounds targeting HCN channels.
- To discuss strategies for exploring HCN channel potential in therapeutic interventions.
Main Methods:
- Literature review of existing studies on HCN channel modulators.
- Analysis of established drugs affecting central nervous system functions.
Main Results:
- HCN channels are implicated in heart rate control and neuronal excitability.
- Existing CNS drugs like lamotrigine, gabapentin, and propofol modulate HCN channel function.
- HCN channels represent promising targets for novel anticonvulsant, anesthetic, and analgesic drugs.
Conclusions:
- HCN channels offer significant therapeutic opportunities beyond cardiovascular applications.
- Further research into HCN channel modulation could lead to new drug development for neurological and pain management.
Abstract:
Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels have a key role in the control of heart rate and neuronal excitability. Ivabradine is the first compound acting on HCN channels to be clinically approved for the treatment of angina pectoris. HCN channels may offer excellent opportunities for the development of novel anticonvulsant, anaesthetic and analgesic drugs. In support of this idea, some well-established drugs that act on the central nervous system - including lamotrigine, gabapentin and propofol - have been found to modulate HCN channel function. This Review gives an up-to-date summary of compounds acting on HCN channels, and discusses strategies to further explore the potential of these channels for therapeutic intervention.
More Related Videos
10:07High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels
Published on: January 27, 2013
07:38Functional Characterization of Na+/H+ Exchangers of Intracellular Compartments Using Proton-killing Selection to Express Them at the Plasma Membrane
Published on: March 30, 2015
Related Concept Videos
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated Ion Channels
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that include the...
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
Patch Clamp
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
Pharmacogenomics: Identification of New Drug Targets
Drug Discovery: Overview